PubRank

Deletion of Mecom in mouse results in early-onset spinal deformity and osteopenia.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4440591)

Published in Bone on December 04, 2013

Authors

Subhash C Juneja1, Alin Vonica2, Caroline Zeiss3, Kimberly Lezon-Geyda4, Bogdan Yatsula5, David R Sell6, Vincent M Monnier7, Sharon Lin8, Thomas Ardito9, David Eyre10, David Reynolds11, Zhenqiang Yao12, Hani A Awad13, Hongbo Yu14, Michael Wilson15, Sylvie Honnons16, Brendan F Boyce17, Lianping Xing18, Yi Zhang19, Archibald S Perkins20

Author Affiliations

1: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA; Department of Orthopedics, University of Rochester Medical Center, USA; Department of Biomedical Engineering, University of Rochester Medical Center, USA. Electronic address: sjuneja.phd@gmail.com.
2: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA. Electronic address: alin_vonica@urmc.rochester.edu.
3: Case Western Reserve University, USA. Electronic address: caroline.zeiss@yale.edu.
4: Department of Pathology, Yale University, USA. Electronic address: kimberly.lezon-geyda@yale.edu.
5: Department of Pathology, Yale University, USA. Electronic address: bogdan.yatsula@yale.edu.
6: Case Western Reserve University, USA. Electronic address: drs7@cwru.edu.
7: Case Western Reserve University, USA. Electronic address: vmm3@cwru.edu.
8: Department of Pathology, Yale University, USA. Electronic address: sharon.lin@yale.edu.
9: Department of Pathology, Yale University, USA. Electronic address: thomas.ardito@yale.edu.
10: University of Washington, Seattle, USA. Electronic address: deyre@u.washington.edu.
11: Department of Orthopedics, University of Rochester Medical Center, USA. Electronic address: david_reynolds@urmc.rochester.edu.
12: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA. Electronic address: zhenqiang_yao@urmc.rochester.edu.
13: Department of Orthopedics, University of Rochester Medical Center, USA; Department of Biomedical Engineering, University of Rochester Medical Center, USA. Electronic address: hani_awad@urmc.rochester.edu.
14: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA. Electronic address: yhb3508@163.com.
15: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA. Electronic address: michael_wilson@urmc.rochester.edu.
16: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA. Electronic address: sylvie.honnons@gmail.com.
17: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA. Electronic address: brendan_boyce@urmc.rochester.edu.
18: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA. Electronic address: lianping_xing@urmc.rochester.edu.
19: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA. Electronic address: yi_zhang@urmc.rochester.edu.
20: Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, USA. Electronic address: archibald_perkins@urmc.rochester.edu.

Articles citing this ↘

Micro CT Analysis of Spine Architecture in a Mouse Model of Scoliosis. Front Endocrinol (Lausanne) (2015) 0.75

Identification of Prdm genes in human corneal endothelium. Exp Eye Res (2017) 0.75

Articles cited by this ↗

Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet (1998) 7.68

Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science (1999) 7.51

PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33

TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development (1997) 6.31

Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev (1994) 4.58

Polycomb complexes and epigenetic states. Curr Opin Cell Biol (2008) 3.81

Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development (2007) 2.92

The genetic program of hematopoietic stem cells. Science (2000) 2.85

Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J Clin Invest (2001) 2.49

Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology (1995) 2.25

Balance disorder and increased risk of falls in osteoporosis and kyphosis: significance of kyphotic posture and muscle strength. Osteoporos Int (2004) 2.18

Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell (2008) 2.05

Recruitment and maintenance of tendon progenitors by TGFbeta signaling are essential for tendon formation. Development (2009) 2.04

Use of dermestid beetles for cleaning bones. Calcif Tissue Int (1980) 1.88

Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. EMBO J (2005) 1.77

Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein. Mol Cell Biol (1991) 1.77

Differential gene expression profiling of adult murine hematopoietic stem cells. Blood (2002) 1.69

Incident vertebral fractures and mortality in older women: a prospective study. Osteoporos Int (2003) 1.64

Nuclear factor I X deficiency causes brain malformation and severe skeletal defects. Mol Cell Biol (2007) 1.59

Transforming growth factor-beta. Major role in regulation of extracellular matrix. Ann N Y Acad Sci (1990) 1.53

The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech Dev (1997) 1.49

Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem (2008) 1.41

Kyphosis does not equal vertebral fractures: the Rancho Bernardo study. J Rheumatol (2004) 1.40

Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development. Development (1991) 1.35

Transforming growth factors beta coordinate cartilage and tendon differentiation in the developing limb mesenchyme. J Biol Chem (2009) 1.35

Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene (1989) 1.33

Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol (2005) 1.30

Adhesions in a murine flexor tendon graft model: autograft versus allograft reconstruction. J Orthop Res (2008) 1.25

PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function. Blood (2011) 1.21

Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice. Dev Biol (2005) 1.20

Prevalence, concordance, and heritability of Scheuermann kyphosis based on a study of twins. J Bone Joint Surg Am (2006) 1.20

Identification of binding sites of EVI1 in mammalian cells. J Biol Chem (2005) 1.16

2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis. Biochem J (2007) 1.15

Impaired intervertebral disc formation in the absence of Jun. Development (2003) 1.15

The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG. Oncogene (1994) 1.12

Immunolocalization of type X collagen in human lumbar intervertebral discs during ageing and degeneration. Histochem Cell Biol (1997) 1.11

The AP1 transcription factor Fra2 is required for efficient cartilage development. Development (2004) 1.11

Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. J Biol Chem (2005) 1.11

Severe thoracic kyphosis in the older patient in the absence of vertebral fracture: association of extreme curve with age. AJNR Am J Neuroradiol (2005) 1.06

Bone architecture and disc degeneration in the lumbar spine of mice lacking GDF-8 (myostatin). J Orthop Res (2003) 1.06

Vertebral alterations in Scheuermann's kyphosis. Spine (Phila Pa 1976) (1991) 1.05

Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP. Oncogene (2005) 1.00

Dominant inheritance of Scheuermann's juvenile kyphosis. J Med Genet (1989) 0.96

Collagen II from articular cartilage and annulus fibrosus. Structural and functional implication of tissue specific posttranslational modifications of collagen molecules. Eur J Biochem (1993) 0.94

EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation. Biochem Biophys Res Commun (2002) 0.94

Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity. Mol Cell Biol (2001) 0.94

Joint hypermobility syndrome pain. Curr Pain Headache Rep (2009) 0.94

The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells. Blood (1998) 0.89

Meta-analysis identifies a MECOM gene as a novel predisposing factor of osteoporotic fracture. J Med Genet (2013) 0.86

Cloning of the murine tetranectin gene and 5'-flanking region. Gene (1997) 0.80

Osteoporosis in Scheuermann's disease. Spine (Phila Pa 1976) (1988) 0.78

Atypical symptom of Ehlers-Danlos syndrome impeding diagnosis: feeling of spinal instability. J Rheumatol (2009) 0.77

["Round back" in children and adolescents]. Rev Med Suisse Romande (2000) 0.76